| |
|
|
|
Innovate Biopharmaceuticals Inc.  
|
|
1.58 -0.07 (-0.04%) |
05-17 16:00 |
|
Open: |
1.64 |
Pre close: |
1.65 |
Target:
|
2.36
|
|
High: |
1.65 |
Low: |
1.56 |
Resistance:
|
2.02
2.40
|
|
Volume: |
1,020,819 |
Market Cap: |
56M |
Support:
|
1.41
1.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.59
 |
MACD |
MACD(12,26):
|
-0.07  |
|
MA(20): |
1.65 |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
2.02 |
Stochastic Oscillator |
%K(14,3):
|
19.19 |
|
MA(250): |
5.44 |
%D(3): |
18.52 |
|
Average Volume(K) |
3-Month: |
100114
|
52-Week |
High:
|
29.09 |
|
10-Days: |
67885 |
Low: |
1.41 |
|
RSI |
RSI(14):
|
43.79 |
Change(%): |
-89.3 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
3746.1 |
Shares Out. (M) |
35.38 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-343.6 |
Shares Float (M) |
34.06 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
17.90 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-15.17 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.51 |
P/CF |
-3.69 |
|
|
|
|
|
|
